Application of glycyrrhizic acid or derivative thereof in nucleic acid detection

CN119032169APending Publication Date: 2024-11-26MGI TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280094839.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-09-09
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In existing nucleic acid detection, high-concentration nucleic acid protective agents are prone to salting out during low-temperature storage and long-term sequencing, and are easily oxidized and discolored, affecting sequencing quality and increasing product costs.

Method used

Glycyrrhizic acid or its derivatives are used as nucleic acid protecting agents to achieve protection of template nucleotides at low concentrations. Glycyrrhizic acid has no absorption in the ultraviolet and visible light regions, does not interfere with base recognition signals, and does not oxidize during long-term storage.

Benefits of technology

It improves the quality of nucleic acid sequencing, especially the accuracy and stability of polynucleotide sequencing, avoids signal interference and oxidative discoloration, and reduces costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000024_0000
    Figure 00000024_0000
  • Figure 00000024_0001
    Figure 00000024_0001
Patent Text Reader

Abstract

The invention relates to application of glycyrrhizic acid or derivatives thereof in nucleic acid detection. In particular, the invention relates to a reagent containing glycyrrhizic acid or a derivative thereof, application of glycyrrhizic acid or the derivative thereof as a nucleic acid protective agent in nucleic acid detection, and a nucleic acid detection method.
Need to check novelty before this filing date? Find Prior Art

Description

Use of glycyrrhizic acid or its derivatives in nucleic acid detection Technical Field

[0001] The present invention relates to the field of nucleic acid detection, and to the use of glycyrrhizic acid or its derivatives in nucleic acid detection. In particular, the present invention relates to a reagent containing glycyrrhizic acid or its derivatives, the use of glycyrrhizic acid or its derivatives as a nucleic acid protective agent in nucleic acid detection, and a nucleic acid detection method. Background Art

[0002] Sequencing by synthesis is the theoretical basis of polynucleotide sequencing and is crucial for base identification during the sequencing process. Typically, base identification is determined by identifying the type of fluorescent dye attached to each base. This process involves exposing the nucleotides to ultraviolet-visible light, causing the chromophore in the fluorescent dye to fluoresce. The fluorescent signal is then detected and photographed, allowing the type of fluorescent dye to be determined.

[0003] Lasers with wavelengths in the ultraviolet-visible range can be used as light sources. However, the continuous strong irradiation from the excitation light source and the reactive oxygen groups in the solution can damage nucleic acids, leading to a loss of fluorescence detection signal intensity and a high error rate, seriously affecting the quality of nucleic acid detection.

[0004] The buffer solution used in the base recognition process is called a scanning reagent or a photographing reagent. Laser damage to the template nucleotides can be prevented by adding a nucleic acid protective agent to the scanning reagent. However, in the prior art, the concentration of the nucleic acid protective agent component in the scanning reagent is relatively high. The use of high-concentration nucleic acid protective agents causes salt precipitation when the scanning reagent is stored at low temperatures or during long sequencing processes. In addition, during long-term storage, some nucleic acid protective components will discolor after oxidation, thereby affecting the scanning quality and, in turn, the sequencing quality of the polynucleotide. In addition, the use of high-concentration nucleic acid protective agents will increase product costs.

[0005] Summary of the Invention

[0006] The present invention uses glycyrrhizic acid or its derivatives as nucleic acid protectants, which can protect template nucleotides even at very low concentrations. Glycyrrhizic acid or its derivatives do not absorb in the ultraviolet-visible region, do not interfere with base recognition signals, and do not discolor even if oxidized during long-term storage.

[0007] Glycyrrhizic acid, also known as glycyrrhizin, is a triterpenoid compound. Its English name is Glycyrrhizic Acid, CAS number is 1405-86-3, and its molecular formula is C 42 H 62 O 16 , molecular weight is 822.93, chemical structure is as follows:

[0008]

[0009] Glycyrrhizic acid is easily soluble in hot water and ethanol, but has a lower solubility in cold water. It can be used in the form of salt or salt hydrate to increase its water solubility.

[0010] This application provides the following inventions:

[0011] In one aspect, the present application provides a reagent comprising glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, and a Tris buffer solution.

[0012] In the present application, the salt of glycyrrhizic acid refers to a salt formed by one, two or three carboxyl groups in glycyrrhizic acid and an appropriate inorganic or organic cation (base), including but not limited to: alkali metal salts, such as sodium salts, potassium salts, lithium salts, etc.; alkaline earth metal salts, such as calcium salts, magnesium salts, etc.; other metal salts, such as aluminum salts, iron salts, zinc salts, copper salts, nickel salts, cobalt salts, etc.; inorganic base salts, such as ammonium salts; organic base salts, such as tert-octylamine salts, dibenzylamine salts, morpholine salts, glucosamine salts, phenylglycine alkyl ester salts, ethylenediamine salts, N-methylglucosamine salts, guanidine salts, diethylamine salts, triethylamine salts, dicyclohexylamine salts, N,N'-dibenzylethylenediamine salts, chloroprocaine salts, procaine salts, diethanolamine salts, N-benzyl-phenethylamine salts, piperazine salts, tetramethylamine salts, tris(hydroxymethyl)aminomethane salts.

[0013] In some embodiments, the salt of glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt, such as a monopotassium salt, a monosodium salt, a monoammonium salt, a dipotassium salt, a disodium salt, a diammonium salt, a tripotassium salt, a trisodium salt, or a triammonium salt.

[0014] In the present application, the hydrate of glycyrrhizic acid or the hydrate of a salt of glycyrrhizic acid refers to a substance formed by the association of glycyrrhizic acid or a salt of glycyrrhizic acid with one or more water molecules. The salt of glycyrrhizic acid can be any of the salts mentioned above.

[0015] In some embodiments, the hydrate of the salt of glycyrrhizic acid is selected from a hydrate of an alkali metal salt or an ammonium salt of glycyrrhizic acid, such as a hydrate of a sodium salt or a potassium salt.

[0016] In some embodiments, the salt of glycyrrhizic acid or the hydrate of the salt of glycyrrhizic acid is selected from:

[0017] Glycyrrhizic acid monoammonium salt, an exemplary structure of which is as follows:

[0018]

[0019] Trisodium glycyrrhizinate hydrate, an exemplary structure of which is as follows:

[0020]

[0021] Glycyrrhizic acid monopotassium salt, an exemplary structure of which is as follows:

[0022]

[0023] Diammonium glycyrrhizate, an exemplary structure of which is as follows:

[0024]

[0025] Dipotassium glycyrrhizate hydrate, an exemplary structure of which is as follows:

[0026]

[0027] In the present invention, the Tris buffer solution refers to a buffer solution using tris (hydroxymethyl)aminomethane (Tris) as a buffer system.

[0028] Tris is widely used in the preparation of buffer solutions in biochemistry and molecular biology. Tris is a weak base, and its aqueous solution has a pH of approximately 10.5. By adding hydrochloric acid to adjust the pH to the desired value, a buffer solution of that pH is obtained. Buffer solutions can also be prepared using Tris and its hydrochloride (Tris-HCl).

[0029] The effective buffering range of Tris buffer solution is between pH 7.0 and 9.2. Tris buffer solution can be used as a solvent for dissolving nucleic acids.

[0030] In the present invention, glycyrrhizic acid or its derivatives can also protect template nucleotides at very low concentrations. In certain embodiments, the concentration of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid is 0.5-3 mM, for example, 0.5-0.6 mM, 0.6-0.7 mM, 0.7-0.8 mM, 0.8-0.9 mM, 0.9-1.0 mM, 1-2 mM, or 2-3 mM.

[0031] In some embodiments, the reagent is a scanning reagent.

[0032] In certain embodiments, the reagent further comprises sodium chloride and / or a DNA stabilizer (e.g., Tween-20). The role of sodium chloride is to provide a salt solution background to protect the primers during detection.

[0033] In certain embodiments, the Tris buffer solution comprises water, Tris Base, sodium chloride, Tween-20 and Tris-HCl.

[0034] In certain embodiments, the Tris buffer solution is prepared by the following method: dissolving Tris Base (powder), sodium chloride (powder), Tween-20, and Tris-HCl (powder) in ultrapure water according to a certain ratio.

[0035] In another aspect, the present application provides use of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid as a nucleic acid protective agent in nucleic acid detection, wherein the salt of glycyrrhizic acid or the hydrate of a salt of glycyrrhizic acid is as defined above.

[0036] In certain embodiments, the nucleic acid protectant is used to protect nucleic acids to reduce or avoid photodamage or oxidative damage.

[0037] In certain embodiments, the nucleic acid detection involves detecting a fluorescent signal. In certain embodiments, the fluorescent signal can be generated by an illumination reaction or a non-illumination reaction (e.g., a bioluminescent reaction). In certain embodiments, the bioluminescent reaction refers to a reaction in which luciferase catalyzes its substrate to produce a fluorescent signal.

[0038] In certain embodiments, the nucleic acid detection involves a light-induced reaction or a non-light-induced reaction (eg, a bioluminescent reaction).

[0039] As used herein, the term "photoreaction" refers to a reaction that is exposed to an optical energy source. Typically, in such reactions, the optical energy source (light) is provided to observe the production and / or consumption of reactants or products, which exhibit specific optical characteristics indicative of their presence, such as changes in the absorption and / or emission spectra (intensity, wavelength, etc.) of the reaction mixture or its components.

[0040] As used herein, the term "non-illuminated reaction" refers to a reaction that can be detected without the aid of an optical energy source. In non-illuminated reactions, the production and / or consumption of reactants or products can be detected by generating an optical signal, such as bioluminescence, or by altering an electrical signal.

[0041] In certain embodiments, the illumination reaction includes a light signal triggered by base extension or a light signal triggered by probe hybridization, and the base extension can cause the generation of an optical signal (such as a fluorescent signal). In certain embodiments, the light signal in the illumination reaction of the present invention is preferably fluorescence.

[0042] In certain embodiments, the nucleic acid detection can be used for nucleic acid sequence determination (sequencing) or other detection (eg, quantitative PCR).

[0043] In certain embodiments, the nucleic acid detection is nucleic acid sequence determination (sequencing), such as high-throughput sequencing, such as sequencing by synthesis (SBS sequencing), ligation sequencing, hybridization sequencing, nanopore sequencing, or combined probe-anchor ligation (cPAL) sequencing.

[0044] In certain embodiments, the nucleic acid detection is quantitative PCR.

[0045] In another aspect, the present application provides a kit comprising the reagents of the present invention.

[0046] In certain embodiments, the kit of the present invention may further comprise one or more other reagents required for nucleic acid detection, for example, primers, polymerase, buffer solution, washing solution, or any combination thereof.

[0047] In certain embodiments, the kits of the present invention are used for nucleic acid sequence determination.

[0048] In certain embodiments, the kit of the present invention may further comprise: a reagent for fixing the nucleic acid molecule to be sequenced to a support (e.g., by covalent or non-covalent attachment); a primer for initiating nucleotide polymerization; a polymerase for carrying out nucleotide polymerization; one or more buffer solutions; one or more washing solutions; or any combination thereof.

[0049] In certain embodiments, the test kit of the present invention may also include reagents and / or devices for extracting nucleic acid molecules from a sample. Methods for extracting nucleic acid molecules from a sample are well known in the art. Therefore, various reagents and / or devices for extracting nucleic acid molecules may be configured as needed in the test kit of the present invention, such as reagents for crushing cells, reagents for precipitating DNA, reagents for washing DNA, reagents for dissolving DNA, reagents for precipitating RNA, reagents for washing RNA, reagents for dissolving RNA, reagents for removing protein, reagents for removing DNA (for example, when the target nucleic acid molecule is RNA), reagents for removing RNA (for example, when the target nucleic acid molecule is DNA), and any combination thereof.

[0050] In certain embodiments, test kit of the present invention also comprises, and is used for the reagent of pre-treatment nucleic acid molecule.In test kit of the present invention, the reagent for pre-treatment nucleic acid molecule is not subject to additional restriction, and can be selected according to actual needs.The described reagent for pre-treatment nucleic acid molecule comprises for example, and is used for the reagent (for example DNA enzyme I) of nucleic acid molecule fragmentation, and is used for the reagent (for example DNA polymerase, for example T4DNA polymerase, Pfu DNA polymerase, Klenow DNA polymerase) of polishing nucleic acid molecule end, joint molecule, label molecule, and is used for the reagent (for example ligase, for example T4DNA ligase) that joint molecule is connected with target nucleic acid molecule, and is used for the reagent (for example, losing 3'-5' exonuclease activity but showing 5'-3' exonuclease activity) of repairing nucleic acid end, and is used for the reagent (for example, DNA polymerase, primer, dNTP) of amplifying nucleic acid molecule, and is used for the reagent (for example chromatography column) of separation and purification nucleic acid molecule, and its any combination.

[0051] In certain embodiments, the kit of the present invention further comprises a support for fixing the nucleic acid molecules to be sequenced. Typically, the support for fixing the nucleic acid molecules to be sequenced is in a solid phase for ease of operation. Therefore, in this disclosure, "support" is sometimes also referred to as "solid support" or "solid phase support." However, it should be understood that the "support" mentioned herein is not limited to solids, and can also be a semi-solid (e.g., a gel).

[0052] As used herein, the terms "loaded," "fixed," and "attached" when used in reference to nucleic acids, mean attached directly or indirectly to a solid support via covalent or non-covalent bonds. In certain embodiments of the present disclosure, the methods of the present invention include immobilizing nucleic acids on a solid support via covalent attachment. Generally, however, it is only required that the nucleic acids remain fixed or attached to the solid support under conditions where the solid support is desired to be used (e.g., in applications where nucleic acid amplification and / or sequencing is required). In certain embodiments, immobilizing nucleic acids on a solid support can include immobilizing an oligonucleotide to be used as a capture primer or an amplification primer on a solid support such that the 3' end is available for enzymatic extension and at least a portion of the primer sequence is capable of hybridizing to a complementary nucleic acid sequence; the nucleic acid to be immobilized is then hybridized to the oligonucleotide, in which case the immobilized oligonucleotide or polynucleotide can be in a 3'-5' direction. In certain embodiments, immobilizing nucleic acids on a solid support can include binding a nucleic acid binding protein to the solid support by amino modification, and capturing nucleic acid molecules by the nucleic acid binding protein. Alternatively, loading can occur by other means besides base pair hybridization, such as covalent attachment as described above. Non-limiting examples of nucleic acid attachment to a solid support include nucleic acid hybridization, biotin-streptavidin binding, sulfhydryl binding, photoactivated binding, covalent binding, antibody-antigen, physical confinement via a hydrogel or other porous polymer, and the like. Various exemplary methods for immobilizing nucleic acids on solid supports can be found in, for example, G. Steinberg-Tatman et al., Bioconjugate Chemistry 2006, 17, 841-848; Xu X. et al. Journal of the American Chemical Society 128 (2006) 9286-9287; U.S. patent applications US 5639603, US 5641658, US2010248991; international patent applications WO 2001062982, WO 2001012862, WO 2007111937, WO0006770, all of which are incorporated herein by reference in their entirety for all purposes, in particular for all teachings relating to the preparation of solid supports having nucleic acids immobilized thereon.

[0053] In the present invention, the support can be made of various suitable materials. Such materials include, for example, inorganic substances, natural polymers, synthetic polymers, and any combination thereof. Specific examples include, but are not limited to, cellulose, cellulose derivatives (e.g., nitrocellulose), acrylic resins, glass, silica gel, silicon dioxide, polystyrene, gelatin, polyvinyl pyrrolidone, copolymers of vinyl and acrylamide, cross-linked polystyrenes such as divinylbenzene (see, for example, Merrifield Biochemistry 1964, 3, 1385-1390), polyacrylamide, latex, dextran, rubber, silicon, plastics, natural sponges, metal plastics, cross-linked dextran (e.g., Sephadex TM ), agarose gel (Sepharose TM ), and other supports known to those skilled in the art.

[0054] In certain preferred embodiments, the support used to immobilize the nucleic acid molecules to be sequenced can be a solid support comprising an inert substrate or matrix (e.g., a glass slide, polymer beads, etc.) that has been functionalized, for example, by applying an intermediate material containing reactive groups that allow for covalent attachment of biomolecules such as polynucleotides. Examples of such supports include, but are not limited to, polyacrylamide hydrogels supported on an inert substrate such as glass, particularly the polyacrylamide hydrogels described in WO 2005 / 065814 and US 2008 / 0280773, the contents of which are incorporated herein by reference in their entirety. In such embodiments, the biomolecules (e.g., polynucleotides) can be directly covalently attached to the intermediate material (e.g., hydrogel), while the intermediate material itself can be non-covalently attached to the substrate or matrix (e.g., a glass substrate). In certain preferred embodiments, the support is a glass or silicon wafer whose surface is modified with a layer of avidin, amino, acrylamide silane, or aldehyde chemical groups.

[0055] In the present invention, the support or solid support is not limited to its size, shape and configuration. In some embodiments, the support or solid support is a planar structure, such as a slide, chip, microchip and / or array. The surface of such a support can be in the form of a planar layer.

[0056] In certain preferred embodiments, the support for immobilizing the nucleic acid molecules to be sequenced is an array of beads or wells (also referred to as a chip). The array can be prepared using any of the materials outlined herein for preparing solid supports, and preferably, the surface of the beads or wells on the array is functionalized to facilitate the immobilization of nucleic acid molecules. The number of beads or wells on the array is not limited. For example, each array may contain 10-10 2 , 10 2-10 3 , 10 3 -10 4 , 10 4 -10 5 , 10 5 -10 6 , 10 6 -10 7 , 10 7 -10 8 , 10 8 -10 9 , 10 10 -10 11 , 10 11 -10 12 In certain exemplary embodiments, the surface of each bead or hole can be fixed with one or more nucleic acid molecules. Accordingly, each array can be fixed with 10-10 2 , 10 2 -10 3 , 10 3 -10 4 , 10 4 -10 5 , 10 5 -10 6 , 10 6 -10 7 , 10 7 -10 8 , 10 8 -10 9 , 10 10 -10 11 , 10 11 -10 12 or more nucleic acid molecules. Therefore, such arrays can be particularly advantageously used for high-throughput sequencing of nucleic acid molecules.

[0057] In certain preferred embodiments, the kit of the present invention further comprises a reagent for fixing the nucleic acid molecule to be sequenced to the support (e.g., by covalent or non-covalent attachment). Such reagents include, for example, reagents for activating or modifying nucleic acid molecules (e.g., their 5' ends), such as phosphoric acid, thiol, amine, carboxylic acid, or aldehyde; reagents for activating or modifying the surface of the support, such as amino-alkoxysilanes (e.g., aminopropyltrimethoxysilane, aminopropyltriethoxysilane, 4-aminobutyltriethoxysilane, etc.); cross-linking agents, such as succinic anhydride, phenyl diisocyanate (Guo et al., 1994), maleic anhydride (Yang et al., 1998), 1-ethyl-3-(3-dimethoxysilane)-1-ol; methylaminopropyl)-carbodiimide hydrochloride (EDC), m-maleimidobenzoic acid-N-hydroxysuccinimide ester (MBS), N-succinimidyl[4-iodoacetyl]aminobenzoic acid (SIAB), 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid succinimide (SMCC), N-γ-maleimidobutyryloxy-succinimide ester (GMBS), 4-(p-maleimidophenyl)butyric acid succinimide (SMPB); and any combination thereof.

[0058] In certain preferred embodiments, the kit of the present invention also includes a primer for initiating nucleotide polymerization. In the present invention, the primer is not subject to additional restrictions, as long as it can specifically anneal to a region of the target nucleic acid molecule. In some exemplary embodiments, the length of the primer can be 5-50bp, such as 5-10, 10-15, 15-20, 20-25, 25-30, 30-35, 35-40, 40-45, 45-50bp. In some exemplary embodiments, the primer can include naturally occurring or non-naturally occurring nucleotides. In some exemplary embodiments, the primer includes naturally occurring nucleotides or is composed of naturally occurring nucleotides. In some exemplary embodiments, the primer includes modified nucleotides, such as locked nucleic acid (LNA). In certain preferred embodiments, the primer includes a universal primer sequence.

[0059] In some preferred embodiments, test kit of the present invention also comprises the polymerase for carrying out nucleotide polymerization reaction.In the present invention, various suitable polymerases can be used to carry out polyreaction.In some exemplary embodiments, described polymerase can be the new DNA chain (such as DNA polymerase) synthesized with DNA as a template.In some exemplary embodiments, described polymerase can be the new DNA chain (such as reverse transcriptase) synthesized with RNA as a template.In some exemplary embodiments, described polymerase can be the new RNA chain (such as RNA polymerase) synthesized with DNA or RNA as a template.Therefore, in some preferred embodiments, described polymerase is selected from DNA polymerase, RNA polymerase, and reverse transcriptase.

[0060] In certain preferred embodiments, the kit of the present invention further comprises one or more excision reagents. In certain embodiments, the excision reagent is selected from endonuclease IV and alkaline phosphatase.

[0061] In certain preferred embodiments, the kit of the present invention further comprises one or more buffer solutions. Such buffer solutions include, but are not limited to, buffer solutions for DNA enzyme I, buffer solutions for DNA polymerase, buffer solutions for ligase, buffer solutions for eluting nucleic acid molecules, buffer solutions for dissolving nucleic acid molecules, buffer solutions for carrying out nucleotide polymerization reactions (e.g., PCR), and buffer solutions for carrying out ligation reactions. The kit of the present invention may comprise any one or more of the above-mentioned buffer solutions.

[0062] In the present invention, "buffer" and "buffer solution" have the same meaning and can be used interchangeably.

[0063] In certain embodiments, the buffer solution for DNA polymerase comprises monovalent salt ions (e.g., sodium ions, chloride ions) and / or divalent salt ions (e.g., magnesium ions, sulfate ions, manganese ions). In certain embodiments, the concentration of the monovalent salt ions or divalent salt ions in the buffer solution is 10 μM-200 mM, e.g., 10 μM, 50 μM, 100 μM, 200 μM, 500 μM, 1 mM, 3 mM, 10 mM, 20 mM, 50 mM, 100 mM, 150 mM, or 200 mM.

[0064] In certain embodiments, the buffer solution for DNA polymerase comprises tris (hydroxymethylaminomethane) (Tris).In certain embodiments, the concentration of Tris in the buffer solution is 10mM-200mM, such as 10mM, 20mM, 50mM, 100mM, 150mM or 200mM.

[0065] In certain embodiments, the buffer solution for DNA polymerase comprises an organic solvent, such as DMSO or glycerol (glycerol). In certain embodiments, the mass content of the organic solvent in the buffer solution is 0.01%-10%, such as 0.01%, 0.02%, 0.05%, 1%, 2%, 5% or 10%.

[0066] In certain embodiments, the pH of the buffer solution for DNA polymerase is 7.0-9.0, e.g., 7.0, 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9, 8.0, 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9 or 9.0.

[0067] In certain embodiments, the buffer solution for DNA polymerase comprises: monovalent salt ions (e.g., sodium ions, chloride ions), divalent salt ions (e.g., magnesium ions, sulfate ions, manganese ions), Tris, and an organic solvent (e.g., DMSO or glycerol). In certain embodiments, the pH of the buffer solution phase is 8.8.

[0068] In certain preferred embodiments, the kit of the present invention further comprises one or more washing solutions. Examples of such washing solutions include, but are not limited to, phosphate buffer, citrate buffer, Tris-HCl buffer, acetate buffer, carbonate buffer, and the like. The kit of the present invention may comprise any one or more of the above-mentioned washing solutions.

[0069] In another aspect, the present application provides the use of the reagent or kit of the present invention for nucleic acid detection. In certain embodiments, the nucleic acid detection involves detecting a fluorescent signal. In certain embodiments, the fluorescent signal can be generated by an illumination reaction or a non-illumination reaction (e.g., a bioluminescent reaction). In certain embodiments, the bioluminescent reaction refers to a reaction in which luciferase catalyzes its substrate to produce a fluorescent signal. In certain embodiments, the nucleic acid detection involves an illumination reaction or a non-illumination reaction (e.g., a bioluminescent reaction). In certain embodiments, the illumination reaction includes a light signal triggered by base extension, and the base extension can cause the generation of an optical signal (e.g., a fluorescent signal). In certain embodiments, the optical feature in the illumination reaction described in the present invention is preferably fluorescence. In certain embodiments, the nucleic acid detection can be used for nucleic acid sequence determination (sequencing) or other detection (e.g., quantitative PCR). In certain embodiments, The nucleic acid detection is nucleic acid sequence determination, such as high-throughput sequencing, such as SBS sequencing, ligation sequencing, hybridization sequencing, nanopore sequencing, or cPAL sequencing. In certain embodiments, the nucleic acid detection is quantitative PCR.

[0070] In another aspect, the present application provides a method for preparing the reagent of the present invention, comprising dissolving the components of the reagent in ultrapure water to form a transparent and uniform solution, and then filtering the solution to obtain the reagent of the present invention. Ultrasound can be used to assist the dissolution.

[0071] In another aspect, the present application provides a method for inhibiting nucleic acid degradation, which comprises using glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid as a nucleic acid protective agent. In some embodiments, the nucleic acid degradation is light-induced nucleic acid degradation or nucleic acid degradation caused by oxidation. In some embodiments, the method comprises: in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, performing an illumination reaction or a non-illumination reaction (e.g., a bioluminescent reaction) on a reaction mixture comprising nucleic acid.

[0072] In another aspect, the present application provides a method for detecting a target nucleic acid molecule, comprising using glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid as a nucleic acid protective agent. In some embodiments, the method comprises: in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, performing an illumination reaction or a non-illumination reaction (e.g., a bioluminescent reaction) on a reaction mixture comprising a target nucleic acid molecule. In certain embodiments, the method comprises: performing signal acquisition and detecting a fluorescent signal on the reaction mixture; wherein the reaction mixture comprises a reactant (e.g., a fluorescently labeled reactant) that can generate a fluorescent signal, a target nucleic acid molecule, and a buffer, and the buffer comprises glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

[0073] In certain embodiments, the fluorescent signal is generated by a photoluminescence reaction or a bioluminescence reaction.

[0074] In certain embodiments, the method comprises: irradiating the reaction mixture with light and detecting a fluorescent signal from the illumination reaction; wherein the reaction mixture comprises a fluorescently labeled reactant, a target nucleic acid molecule, and a buffer, and the buffer comprises glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

[0075] In certain embodiments, the reaction mixture for performing the light irradiation reaction comprises glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

[0076] In certain embodiments, the method is used for nucleic acid sequence determination. In certain embodiments, the sequencing is high-throughput sequencing. In certain embodiments, the sequencing is SBS sequencing, ligation sequencing, hybridization sequencing, nanopore sequencing, or cPAL sequencing.

[0077] In certain embodiments, the reactants that can generate a fluorescent signal include: labeled or unlabeled nucleotides (e.g., dNTPs), optionally further comprising other reagents that allow the reactants to generate a fluorescent signal. In certain embodiments, each reactant that can generate a fluorescent signal corresponds to a type of nucleotide, and each reactant can generate a signal that is distinguishable from each other to identify the incorporation of a specific nucleotide. For example, four reactants each containing adenine, guanine, cytosine, and thymine to be incorporated can generate different fluorescent signals, making them easy to distinguish from each other.

[0078] In certain embodiments, the nucleotides in the reactant capable of generating a fluorescent signal (eg, fluorescently labeled nucleotides) further carry a blocking group (eg, a 3' blocking group) to reversibly prevent further base extension.

[0079] In certain embodiments, the nucleotides (eg, fluorescently labeled nucleotides) in the reactants capable of generating a fluorescent signal are selected from nucleoside polyphosphates (or analogs thereof), such as dNTPs.

[0080] In certain embodiments, the reaction mixture further comprises an enzyme, such as a polymerase, a helicase, an exonuclease, or a ligase; preferably, the reaction mixture comprises a polymerase, such as a DNA polymerase.

[0081] In certain embodiments, the reaction mixture further comprises a primer.

[0082] In certain embodiments, the method comprises: incorporating nucleotides (e.g., fluorescently labeled nucleotides) in the reactant that can generate a fluorescent signal into the complementary strand of the target nucleic acid molecule; in the presence of a buffer comprising glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, providing conditions that allow the reactant to generate a fluorescent signal and detecting the fluorescent signal of the reaction mixture (e.g., irradiating the reaction mixture), and determining the identity of the incorporated nucleotide. In certain embodiments, determining the identity of the incorporated nucleotide comprises detecting (e.g., taking a photograph of) a fluorescent signal (e.g., a fluorescent label) associated with the incorporated nucleotide.

[0083] In certain embodiments, the method further comprises: removing a moiety (e.g., a fluorescent label) that is directly or indirectly attached to the incorporated nucleotide and that generates a fluorescent signal; and / or, washing to remove unincorporated nucleotides. In certain embodiments, the method further comprises: removing a blocking group from the incorporated nucleotide to allow further extension.

[0084] In certain embodiments, the methods comprise multiple incorporations and determining the identity of the base present in each incorporated nucleotide to determine the sequence of the target nucleic acid molecule.

[0085] In certain embodiments, the target nucleic acid molecule is present in a nucleic acid array. In certain embodiments, each site on the array can include multiple copies of a single target nucleic acid molecule. In certain embodiments, the nucleic acid array is fixed to a solid support, such as a chip.

[0086] In another aspect, the present application provides a method for detecting a nucleic acid sequence, comprising: incorporating one or more labeled modified nucleotides into a nucleic acid chain complementary to a nucleic acid template chain, and determining the type of the one or more incorporated nucleotides by detecting the label, wherein the step of determining the type of the incorporated nucleotides is carried out in a buffer comprising glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

[0087] In certain embodiments, the label is a label that can generate a fluorescent signal. In certain embodiments, the fluorescent signal is generated by an illumination reaction or a bioluminescent reaction. In certain embodiments, the method is used for nucleic acid sequence determination (sequencing). In certain embodiments, the nucleotide with a label modification is: (1) a fluorescently labeled nucleotide (e.g., dNTP); or (2) a nucleotide with a label (e.g., dNTP), and the label can specifically bind to luciferase.

[0088] In certain embodiments, the step of determining the type of incorporated nucleotide comprises: in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, providing conditions that allow the label to generate a fluorescent signal and detecting the fluorescent signal of the buffer solution, and determining the identity of the incorporated nucleotide. Optionally, the method further comprises: removing from the incorporated nucleotide a portion that is directly or indirectly attached thereto and that can generate a fluorescent signal; and / or, washing to remove unincorporated nucleotides. In certain embodiments, the method comprises multiple incorporations and determining the identity of the base present in each incorporated nucleotide to determine the sequence of the target nucleic acid molecule.

[0089] In certain embodiments, the salt of the glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt. In certain embodiments, the hydrate of the salt of the glycyrrhizic acid is selected from a hydrate of an alkali metal salt or an ammonium salt of glycyrrhizic acid. In certain embodiments, the salt of the glycyrrhizic acid or the hydrate of the salt of the glycyrrhizic acid is selected from: glycyrrhizic acid monoammonium salt, glycyrrhizic acid trisodium hydrate, glycyrrhizic acid monopotassium salt, glycyrrhizic acid diammonium salt, glycyrrhizic acid dipotassium hydrate. In certain embodiments, in the buffer solution, the concentration of the hydrate of glycyrrhizic acid, glycyrrhizic acid salt or the salt of glycyrrhizic acid is 0.5-3mM. In certain embodiments, the buffer solution also includes a stabilizer (such as Tween-20) for sodium chloride and / or DNA.

[0090] In certain embodiments, the buffer solution is a scanning reagent.

[0091] In certain embodiments, the method is used for nucleic acid sequence determination. In certain embodiments, the sequencing is high-throughput sequencing. In certain embodiments, the sequencing is SBS sequencing, ligation sequencing, hybridization sequencing, nanopore sequencing, or cPAL sequencing.

[0092] Light-induced sequencing

[0093] In certain embodiments, the fluorescent signal is generated by an illumination reaction. In such embodiments, the label is preferably a fluorescent label. In certain embodiments, the method comprises: irradiating the reaction mixture with light, and detecting a fluorescent signal from the illumination reaction; wherein the reaction mixture comprises a reactant capable of generating a fluorescent signal, a target nucleic acid molecule, and a buffer, wherein the buffer comprises glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid. In certain embodiments, the reaction mixture subjected to the illumination reaction comprises glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

[0094] In certain embodiments, the reactants capable of generating a fluorescent signal include fluorescently labeled nucleotides (e.g., dNTPs). In certain embodiments, the fluorescent label can be linked to the nucleotide (e.g., its base) via a linker. The linker can be acid-labile, photolabile, or contain a disulfide bond.

[0095] In certain embodiments, the method comprises: incorporating fluorescently labeled nucleotides into the complementary strand of the target nucleic acid molecule; irradiating the reaction mixture in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, and determining the identity of the incorporated nucleotides. In certain embodiments, determining the identity of the incorporated nucleotides comprises detecting (e.g., taking a photo of) the fluorescent label of the incorporated nucleotides. In certain embodiments, the method further comprises: removing the fluorescent label attached to the incorporated nucleotides; and / or, washing to remove unincorporated nucleotides. In certain embodiments, the method further comprises: removing blocking groups from the incorporated nucleotides to allow further extension.

[0096] In certain embodiments, the reactants that can generate fluorescent signals include: unlabeled nucleotides (e.g., dNTPs) and fluorescently labeled affinity reagents (e.g., antibodies), and the affinity reagents can specifically bind to the unlabeled nucleotides. Such embodiments may be referred to as Cool MPS sequencing, and detailed teachings thereof may refer to PCT International Application WO2018129214A1. In such embodiments, based on the SBS sequencing principle, the fluorescent group is not directly labeled on the incorporated nucleotides, but is labeled on an affinity reagent (e.g., an antibody, an aptamer, an Affimer, a Knottin, etc.), and the affinity reagent can specifically bind to the bases, sugars, cleavable blocking groups, or a combination of these components incorporated into the nucleotides, and therefore the type of incorporated nucleotides can be identified by the affinity reagent.

[0097] In certain embodiments, the method comprises: incorporating unlabeled nucleotides into the complementary strand of the target nucleic acid molecule; providing a fluorescently labeled affinity reagent, and indirectly connecting the fluorescent label to the incorporated nucleotide by specific binding between the affinity reagent and the nucleotide; irradiating the reaction mixture in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, and determining the identity of the incorporated nucleotide. In certain embodiments, the determination of the identity of the incorporated nucleotide comprises detecting (e.g., taking a photo of) the fluorescent label of the affinity reagent to which the incorporated nucleotide is attached. In certain embodiments, the method further comprises: removing the affinity reagent attached to the incorporated nucleotide; and / or, washing to remove unincorporated nucleotides. In certain embodiments, the method further comprises: removing the blocking group from the incorporated nucleotide to allow further extension.

[0098] Sequencing based on bioluminescence reactions

[0099] In certain embodiments, the fluorescent signal is generated by a bioluminescent reaction. The detection principle of bioluminescence includes that the nucleotide to be incorporated is not directly labeled with a fluorescent signal, but is labeled with an affinity substance such as biotin or digoxin. After the polymerization reaction, a pairing member of the above affinity substance with luciferase is added to bind the luciferase to the incorporated nucleotide, and then a reaction substrate is added to generate a light signal to identify the identity of the incorporated nucleotide. This process does not require excitation light irradiation. Detailed teachings on bioluminescent reactions can be found in, for example, PCT International Application WO2020227953A1.

[0100] In certain embodiments, the reactants capable of generating a fluorescent signal include: a nucleotide with a tag (eg, dNTP), a luciferase capable of specifically binding to the tag, and a substrate of the luciferase.

[0101] In certain embodiments, the tag carried by the nucleotide is a member of any molecular pair that can specifically bind to each other. Specific binding between the pairing members realizes the connection between the nucleotide and the luciferase. Exemplary pairing members include, but are not limited to: (a) haptens or antigenic compounds in combination with corresponding antibodies or their binding portions or fragments, such as digoxin-digoxin antibodies, N3G-N3G antibodies, FITC-FITC antibodies; (b) nucleic acid aptamers and proteins; (c) non-immune binding pairs (e.g., biotin-avidin, biotin-streptavidin, biotin-neutravidin); (d) hormone-hormone binding protein; (e) receptor-receptor agonist or antagonist; (f) lectin-carbohydrate; (g) enzyme-enzyme cofactor; (h) enzyme-enzyme inhibitor; and (i) complementary oligonucleotides or polynucleotides capable of forming nucleic acid duplexes.

[0102] In certain embodiments, the label carried by the nucleotide is a small molecule label selected from biotin, digoxigenin, N3G or FITC, and the luciferase carries a pairing member corresponding to the small molecule label. For example, in a specific embodiment, if the label carried by the nucleotide is biotin, the luciferase can be a luciferase labeled with streptavidin; if the label carried by the nucleotide is digoxigenin, the luciferase can be a luciferase labeled with a digoxigenin antibody. The sources of the luciferase include but are not limited to organisms such as firefly, gaussia, and Renilla. For example, the luciferase labeled with streptavidin can be SA-Gluc:Streptavidin-Gaussia princeps luciferase from Adivity. The luciferase labeled with a digoxigenin antibody can be digoxin antibody-Gluc or digoxin antibody-Nluc.

[0103] In certain embodiments, the method comprises: incorporating a tagged nucleotide into a complementary strand of a target nucleic acid molecule; providing a luciferase connected to a pairing member capable of specifically binding to the tag, and indirectly connecting the luciferase to the incorporated nucleotide through specific binding between the pairing members; providing a substrate for the luciferase in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid to generate a fluorescent signal, thereby determining the identity of the incorporated nucleotide. In certain embodiments, the method further comprises: removing the luciferase connected to the incorporated nucleotide; and / or, washing to remove unincorporated nucleotides. In certain embodiments, the method further comprises: removing a blocking group from the incorporated nucleotide to allow further extension.

[0104] In certain embodiments, the method can also be used for quantitative PCR. In certain embodiments, the reactant that can generate a fluorescent signal is a fluorescent probe. In certain embodiments, the reaction mixture further comprises an enzyme, such as a polymerase, a helicase, an exonuclease, or a ligase; preferably, the reaction mixture comprises a polymerase, such as a DNA polymerase. In certain embodiments, the reaction mixture further comprises a primer.

[0105] In the method for inhibiting nucleic acid degradation of the present invention or the method for detecting target nucleic acid molecules, the salt of the glycyrrhizic acid or the hydrate of the salt of the glycyrrhizic acid can be selected from any salt or hydrate defined above. In certain embodiments, the salt of the glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt. In certain embodiments, the hydrate of the salt of the glycyrrhizic acid is selected from a hydrate of an alkali metal salt or an ammonium salt of glycyrrhizic acid. In certain embodiments, the salt of the glycyrrhizic acid or the hydrate of the salt of the glycyrrhizic acid is selected from: glycyrrhizic acid monoammonium salt, glycyrrhizic acid trisodium hydrate, glycyrrhizic acid monopotassium salt, glycyrrhizic acid diammonium salt, glycyrrhizic acid dipotassium hydrate. In certain embodiments, the glycyrrhizic acid, the salt of the glycyrrhizic acid or the hydrate of the salt of the glycyrrhizic acid is present in a buffer solution, and the concentration is 0.5-3mM. In certain embodiments, the buffer solution also comprises a stabilizer (such as Tween-20) for sodium chloride and / or DNA.

[0106] The following discussion will use synthesis sequencing as an example, which is not meant to be limiting. All uses and methods of using the reagents of the present invention in a nucleic acid detection step involving an illumination reaction are within the scope of the present invention.

[0107] In another aspect, the present application provides a method for nucleic acid sequencing, comprising using the reagents of the present invention. In certain embodiments, the sequencing method of the present invention comprises synthesizing a growing polynucleotide complementary to a target single-stranded polynucleotide, followed by scanning and photographing for detection.

[0108] In certain embodiments, the method for determining the sequence of a target single-stranded polynucleotide comprises:

[0109] (a) providing a duplex, nucleotides, a polymerase, and an excision reagent; the duplex comprises a growing nucleic acid chain and a nucleic acid molecule to be sequenced;

[0110] (b) performing a reaction cycle comprising the following steps (i), (ii) and (iii):

[0111] Step (i): using a polymerase to incorporate nucleotides into the growing nucleic acid chain to form a nucleic acid intermediate comprising a blocking group and a detectable label;

[0112] Step (ii): detecting the detectable label on the nucleic acid intermediate in the presence of a reagent of the present invention;

[0113] Step (iii): using a cleavage reagent to remove the blocking group on the nucleic acid intermediate.

[0114] In certain embodiments, the reaction cycle further comprises step (iv): removing the detectable label on the nucleic acid intermediate using a cleavage reagent.

[0115] In certain embodiments, the method comprises the steps of:

[0116] The first step is to load DNA nanoballs (DNBs) onto the prepared sequencing chip;

[0117] In the second step, the prepared dNTP molecule mixture solution is pumped into the chip and DNA polymerase is used to add dNTPs to the complementary strand of the DNA to be tested;

[0118] The third step is photo scanning. Since dNTPs are modified molecules with fluorescent groups, laser is used as the excitation wavelength for photography. Since laser can cause photodamage to DNA, a scanning reagent containing a nucleic acid protectant is added during this step to take photos.

[0119] In the fourth step, the base-end fluorescent group and the 3' blocker are removed and washed away by the removal reagent, leaving the 3'-OH group exposed for the next round of reaction.

[0120] The fifth step is to determine the base sequence of the nucleic acid molecule to be tested by analyzing the photographic results.

[0121] In the present invention, nucleic acids may include nucleotides or nucleotide analogs. Nucleotides generally contain a sugar, a nucleobase, and at least one phosphate group. Nucleotides include deoxyribonucleotides, modified deoxyribonucleotides, ribonucleotides, modified ribonucleotides, peptide nucleotides, modified peptide nucleotides, modified phosphate sugar backbone nucleotides, and mixtures thereof. Examples of nucleotides include, for example, adenosine monophosphate (AMP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), thymidine monophosphate (TMP), thymidine diphosphate (TDP), thymidine triphosphate (TTP), cytidylic acid (CMP), cytidylic acid diphosphate (CDP), cytidylic acid triphosphate (CTP), guanosine monophosphate (GMP), guanosine diphosphate (GDP), guanosine triphosphate (GTP), Uridine monophosphate (UMP), uridine diphosphate (UDP), uridine triphosphate (UTP), deoxyadenylic acid (dAMP), deoxyadenosine diphosphate (dADP), deoxyadenosine triphosphate (dATP), deoxythymidine monophosphate (dTMP), deoxythymidine diphosphate (dTDP), deoxythymidine triphosphate (dTTP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP), deoxyguanosine monophosphate (dGMP), deoxyguanosine diphosphate (dGDP), deoxyguanosine triphosphate (dGTP), deoxyuridine monophosphate (dUMP), deoxyuridine diphosphate (dUDP) and deoxyuridine triphosphate (dUTP). Nucleotide analogs comprising modified nucleobases can also be used in the methods described herein. Exemplary modified nucleobases that can be included in polynucleotides, whether having a natural backbone or an analogous structure, include, for example, inosine, xanthine, hypoxanthine, isocytosine, isoguanine, 2-aminopurine, 5-methylcytosine, 5-hydroxymethylcytosine, 2-aminoadenine, 6-methyladenine, 6-methylguanine, 2-propylguanine, 2-propyladenine, 2-thiouracil, 2-thiothymine, 2-thiocytosine, 15-halouracil, 15-halocytosine, 5-propynyluracil, 5-propynyl Cytosine, 6-azouracil, 6-azocytosine, 6-azothymidine, 5-uracil, 4-thiouracil, 8-haloadenine or guanine, 8-aminoadenine or guanine, 8-thioadenine or guanine, 8-sulfanyladenine or guanine, 8-hydroxyadenine or guanine, 5-halosubstituted uracil or cytosine, 7-methylguanine, 7-methyladenine, 8-azaguanine, 8-azaadenine, 7-deazaguanine, 7-deazaadenine, 3-deazaguanine, 3-deazaadenine, etc. As is known in the art, certain nucleotide analogs cannot be incorporated into polynucleotides, for example, nucleotide analogs such as adenosine 5'-phosphosulfate.

[0122] In the method of the present invention, the nucleic acid molecule to be sequenced is not limited by its length. In certain preferred embodiments, the length of the nucleic acid molecule to be sequenced can be at least 10bp, at least 20bp, at least 30bp, at least 40bp, at least 50bp, at least 100bp, at least 200bp, at least 300bp, at least 400bp, at least 500bp, at least 1000bp, or at least 2000bp. In certain preferred embodiments, the length of the nucleic acid molecule to be sequenced can be 10-20bp, 20-30bp, 30-40bp, 40-50bp, 50-100bp, 100-200bp, 200-300bp, 300-400bp, 400-500bp, 500-1000bp, 1000-2000bp, or more than 2000bp. In certain preferred embodiments, the nucleic acid molecule to be sequenced can have a length of 10-1000bp, to facilitate high-throughput sequencing.

[0123] In certain preferred embodiments, the nucleic acid molecules may be pretreated before being fixed to a support. Such pretreatments include, but are not limited to, fragmentation of the nucleic acid molecules, end-padding, addition of adapters, addition of tags, amplification of the nucleic acid molecules, separation and purification of the nucleic acid molecules, and any combination thereof.

[0124] The term "nanosphere" as used herein generally refers to a macromolecule or complex having a compact, (approximately) spherical shape, eg, with an inner diameter typically ranging between about 1 nm and about 1000 nm, preferably between about 50 nm and about 500 nm.

[0125] As used herein, the term "nucleic acid nanoball" is generally a concatemer comprising multiple copies of a target nucleic acid molecule. These nucleic acid copies are typically arranged one after another in a continuous linear chain of nucleotides, but the nucleic acid nanoballs of the present invention can also be made from any nucleic acid molecule using the methods described herein. This tandem repeat structure, together with the single-stranded nature of DNA, causes the nanoball to fold (folding) configuration. Generally speaking, the multiple copies of the target nucleic acid molecules in the nucleic acid nanoball each contain a linker sequence with a known sequence to facilitate amplification or sequencing thereof. The linker sequences of each target nucleic acid molecule are generally the same, but may also be different. Nucleic acid nanoballs generally include DNA nanoballs, also referred to herein as DNBs (DNA nanoballs).

[0126] Nucleic acid nanospheres can be produced using, for example, rolling circle replication (RCA). The RCA process has been used to prepare multiple continuous copies of the M13 genome (Blanco et al., (1989) J Biol Chem 264:8935-8940). In this method, nucleic acids are replicated through linear concatemerization. Those skilled in the art can find guidance on the conditions and reagents for selecting RCA reactions in many references, including U.S. Patents US5,426,180, US5,854,033, US6,143,495 and US5,871,921, for all purposes, particularly for all teachings related to the preparation of nucleic acid nanospheres using RCA or other methods, which are incorporated herein by reference in their entirety.

[0127] The nucleic acid nanospheres can be loaded onto the surface of a solid support as described herein. The nanospheres can be attached to the surface of the solid support by any suitable method, non-limiting examples of which include nucleic acid hybridization, biotin-streptavidin binding, sulfhydryl binding, photoactivated binding, covalent binding, antibody-antigen, physical confinement via a hydrogel or other porous polymer, or a combination thereof. In some cases, the nanospheres can be digested with a nuclease (e.g., a DNA nuclease) to generate smaller nanospheres or fragments from the nanospheres.

[0128] In certain embodiments, the solid support surface may have reactive functional groups that react with complementary functional groups on the polynucleotide molecules to form covalent bonds, for example, using the same techniques used to attach cDNA to microarrays, for example, see Smirnov et al. (2004), Genes, Chromosomes & Cancer, 40: 72-77 and Beaucage (2001), Current Medicinal Chemistry, 8: 1213-1244, both of which are incorporated herein by reference. DNB can also effectively attach to hydrophobic surfaces, such as clean glass surfaces with low concentrations of various reactive functional groups (e.g., -OH groups). Attachment via covalent bonds formed between polynucleotide molecules and reactive functional groups on the surface is also referred to herein as "chemical attachment."

[0129] In other embodiments, the polynucleotide molecules can be adsorbed onto a surface. In this embodiment, the polynucleotide is immobilized by non-specific interactions with the surface, or by non-covalent interactions such as hydrogen bonds, van der Waals forces, etc.

[0130] In other embodiments, the nucleic acid library can be double-stranded nucleic acid fragments, which are immobilized on the surface of a solid support by a ligation reaction with oligonucleotides immobilized on the surface of a solid support, and then a bridge amplification reaction is performed to prepare a sequencing library. Beneficial effects

[0131] The present invention can achieve the following beneficial effects:

[0132] The present invention uses glycyrrhizic acid or its derivatives as nucleic acid protectants, enabling protection of template nucleotides even at very low concentrations. The glycyrrhizic acid or its derivatives used in the present invention do not absorb in the ultraviolet-visible region, ensuring high data quality even after multiple rounds of sequencing reactions, without interfering with base recognition signals. Furthermore, the optimized scanning reagents used in the present invention do not discolor during long-term storage due to oxidation. The quality of nucleic acid sequencing, particularly polynucleotide sequencing, can be significantly improved by using the optimized scanning reagents.

[0133] The embodiments of the present invention will be described in detail below with reference to the accompanying drawings and examples. However, it will be understood by those skilled in the art that the following drawings and examples are intended only to illustrate the present invention and are not intended to limit the scope of the invention. Various objects and advantages of the present invention will become apparent to those skilled in the art based on the following detailed description of the accompanying drawings and preferred embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0134] FIG1 shows the effects of different concentrations of glycyrrhizic acid on the Q30 of sequencing in Example 1.

[0135] FIG2 shows the effects of different concentrations of glycyrrhizic acid on sequencing lag in Example 1. DETAILED DESCRIPTION

[0136] The embodiments of the present invention will be described in detail below with reference to the examples, but it will be understood by those skilled in the art that the following examples are merely illustrative of the present invention and should not be construed as limiting the scope of the invention. Where specific conditions are not specified in the examples, the methods were performed according to conventional conditions or the conditions recommended by the manufacturer. Where the manufacturers of the reagents or instruments are not specified, they are all conventional products that can be obtained commercially.

[0137] Example

[0138] 1. Experimental equipment

[0139] MGISEQ-2000RS sequencer, MGIDL-200H loader, MGISEQ-2000RS sequencing slide, MGISEQ-2000RS High-throughput Sequencing Reagent Set FCLPE150, instrument excitation wavelengths: 532nm, 650nm respectively.

[0140] 2. Reagents and Materials Used in the Experiment

[0141] Tris Base (powder), sodium chloride (powder), Tween-20, Tris-HCl (powder), and glycyrrhizic acid were purchased from a compliant chemical reagent supplier. The MGISEQ-2000RS High-Throughput Sequencing Kit, catalog number 1000012536, is manufactured by MGI. Escherichia coli single-stranded circular DNA was used as the template, i.e., Standard Library Reagent V3.0. DNA polymerase (Cpas DNA Polymerase) was from MGI. DNB nanospheres were from MGI. dATP-1 (an adenine nucleotide modified with a reversible blocking group and a Cy5 fluorescent marker); dTTP-1 (a thymine nucleotide modified with a reversible blocking group and a ROX fluorescent marker); dGTP-1 (a guanine nucleotide modified with a reversible blocking group and a Cy3 fluorescent marker); and dCTP-1 (a cytosine nucleotide modified with a reversible blocking group and an EF700 fluorescent marker) were all from MGI.

[0142] 3. Experimental methods:

[0143] (a) Preparation of scanning reagents

[0144] Take HotMPS Image Reagent V2.0, add a certain amount of glycyrrhizic acid powder to it and dissolve it by ultrasonication for 20 minutes to prepare the required concentration. The specific amount is shown in Table 1. The above reagent is dissolved into a transparent and uniform solution, and filtered through a 0.22-μm filter membrane for use.

[0145] Table 1: Experimental conditions of glycyrrhizic acid working solution

[0146] The amount of glycyrrhizic acid added to the blank control was the final working solution concentration of glycyrrhizic acid: 0.822 g 1 mM 1.644 g 2 mM 2.466 g 3 mM

[0147] Note: The blank control is the commercial HotMPS scanning reagent V2.0.

[0148] (b) DNA sequencing method:

[0149] Sequencing process: The first step is to load the DNB nanospheres onto the prepared sequencing chip.

[0150] In the second step, the prepared dNTP molecule mixed solution is pumped into the chip and DNA polymerase is used to add dNTPs to the complementary chain of the DNA mother chain.

[0151] The third step is to take a photo and scan. Since dNTPs are modified molecules with fluorescent groups, laser excitation is used to take photos. Since lasers can damage DNA, a scanning reagent is used as a protective agent during this step. After taking the photos, the base type is confirmed.

[0152] In the fourth step, the base-end fluorescent group and the 3' blocker are removed and washed away by the removal reagent, so that the 3'-OH is exposed for the next round of reaction.

[0153] The MGISEQ-2000RS high-throughput sequencing kit was used, and the reagent in well #10 in the kit was used as the control for the scanning reagent. PE100+70 sequencing was performed on the MGISEQ-2000RS sequencing platform according to the above experimental process. In short, the prepared scanning reagent was used as the experimental group each time, and the scanning reagent #10 in the kit was replaced as the object of investigation. The decrease in Q30 of each cycle and the sequencing error rate curve of each cycle were then calculated to evaluate the sequencing quality.

[0154] Example 1 Evaluation of the effect of glycyrrhizic acid concentration on sequencing quality

[0155] Following the above experimental method, blank controls and various concentrations of glycyrrhizic acid were subjected to PE150 sequencing. The results are shown in Figure 1. The results demonstrate that a 1.00 mM glycyrrhizic acid solution effectively improves the Q30 value of duplex sequencing, with the improvement reaching 6.8% in the final cycle. However, at high concentrations, the antioxidant itself undergoes autooxidation, which is detrimental to sequencing quality, as shown in the test results for 2.00 and 3.00 mM glycyrrhizic acid solutions.

[0156] Figure 2 shows the effect of different glycyrrhizic acid concentrations on sequencing lag. A 1.00 mM glycyrrhizic acid solution effectively reduced the lag of the second strand. This is likely due to the antioxidant glycyrrhizic acid providing excellent protection for the DNB nanospheres and the first strand during first-strand sequencing. The experimental conditions for the blank control are shown in Table 1, as are the working concentrations of glycyrrhizic acid.

[0157] The above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit the scope of the present invention. Any modification or equivalent replacement of the technical solutions of the present invention without departing from the purpose and scope of the technical solutions of the present invention should be included in the scope of protection of the present invention.

Claims

1. A reagent comprising glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, and a Tris buffer solution; Preferably, the salt of glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt; Preferably, the hydrate of the salt of glycyrrhizic acid is selected from the hydrate of the alkali metal salt or ammonium salt of glycyrrhizic acid; Preferably, the salt of glycyrrhizic acid or the hydrate of the salt of glycyrrhizic acid is selected from the group consisting of: glycyrrhizic acid monoammonium salt, glycyrrhizic acid trisodium hydrate, glycyrrhizic acid monopotassium salt, glycyrrhizic acid diammonium salt, and glycyrrhizic acid dipotassium hydrate; Preferably, in the reagent, the concentration of glycyrrhizic acid, a salt of glycyrrhizic acid or a hydrate of a salt of glycyrrhizic acid is 0.5-3 mM; Preferably, the reagent further comprises sodium chloride and / or a DNA stabilizer (such as Tween-20).

2. Use of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid as a nucleic acid protective agent in nucleic acid detection; Preferably, the nucleic acid detection involves a light-induced reaction or a non-light-induced reaction; Preferably, the nucleic acid detection involves a sequencing reaction; Preferably, the salt of glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt; Preferably, the hydrate of the salt of glycyrrhizic acid is selected from the hydrate of the alkali metal salt or ammonium salt of glycyrrhizic acid; Preferably, the salt of glycyrrhizic acid or the hydrate of the salt of glycyrrhizic acid is selected from the group consisting of: glycyrrhizic acid monoammonium salt, glycyrrhizic acid trisodium hydrate, glycyrrhizic acid monopotassium salt, glycyrrhizic acid diammonium salt, and glycyrrhizic acid dipotassium hydrate.

3. The use according to claim 2, wherein The nucleic acid detection is nucleic acid sequence determination, such as high-throughput sequencing; for example, SBS sequencing, ligation sequencing, hybridization sequencing, nanopore sequencing, or cPAL sequencing.

4. The use according to claim 2, wherein The nucleic acid detection is quantitative PCR.

5. A kit comprising the reagent of claim 1; Preferably, the kit further comprises one or more other reagents required for nucleic acid detection, such as primers, polymerase, buffer solution, washing solution, or any combination thereof.

6. A method for detecting a nucleic acid sequence, comprising: One or more labeled modified nucleotides are incorporated into a nucleic acid chain complementary to a nucleic acid template chain, and the type of the one or more incorporated nucleotides is determined by detecting the label, wherein the step of determining the type of the incorporated nucleotide is carried out in a buffer solution containing glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid.

7. The method of claim 6, wherein the label is a label that can generate a fluorescent signal; Preferably, the fluorescent signal is generated by a light reaction or a bioluminescent reaction; Preferably, the labeled modified nucleotide is: (1) a fluorescently labeled nucleotide (eg, dNTP); or (2) a nucleotide with a tag (eg, dNTP), wherein the tag can specifically bind to luciferase.

8. The method according to claim 7, wherein The step of determining the type of the incorporated nucleotide comprises: providing conditions that allow the label to generate a fluorescent signal in the presence of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid, and detecting the fluorescent signal of the buffer solution, and determining the identity of the incorporated nucleotide; Optionally, the method further comprises: removing from the incorporated nucleotide a portion directly or indirectly linked thereto that can generate a fluorescent signal; and / or, washing to remove unincorporated nucleotides; Preferably, the method comprises multiple incorporation and determining the identity of the base present in each incorporated nucleotide to determine the sequence of the target nucleic acid molecule.

9. The method according to any one of claims 6 to 8, wherein The salt of glycyrrhizic acid is selected from an alkali metal salt or an ammonium salt; Preferably, the hydrate of the salt of glycyrrhizic acid is selected from the hydrate of the alkali metal salt or ammonium salt of glycyrrhizic acid; Preferably, the salt of glycyrrhizic acid or the hydrate of the salt of glycyrrhizic acid is selected from the group consisting of: glycyrrhizic acid monoammonium salt, glycyrrhizic acid trisodium hydrate, glycyrrhizic acid monopotassium salt, glycyrrhizic acid diammonium salt, and glycyrrhizic acid dipotassium hydrate; Preferably, in the buffer solution, the concentration of glycyrrhizic acid, a salt of glycyrrhizic acid, or a hydrate of a salt of glycyrrhizic acid is 0.5-3 mM; Preferably, the buffer solution further comprises sodium chloride and / or a DNA stabilizer (such as Tween-20); Preferably, the buffer solution is a scanning reagent.